Abstract
Viral infections, as well as other infectious diseases, are a global public health problem due to the severity of their symptoms and the high costs associated with preventive and therapeutic measures, as observed during the SARS-CoV-2 pandemic. Regarding the available therapies, the use of antivirals stands out. However, a concern about these therapeutic agents is the development of resis…